Related Experiment Videos

[Lp(a) lipoprotein in patients on maintenance hemodialysis--a study from apo(a) isoform]

H Ohashi1, H Oda, Y Matsuno

  • 1Division of Nephrology, Prefectural Gifu Hospital, Japan.

Insights

Patients on maintenance hemodialysis (HD) have higher lipoprotein(a) [Lp(a)] levels and distinct apo(a) isoform patterns compared to healthy individuals. These findings highlight potential cardiovascular risks associated with Lp(a) in dialysis patients.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Clinical Chemistry

Context:

  • Lipid abnormalities are implicated in cardiovascular disorders among patients undergoing maintenance hemodialysis (HD).
  • Hypertriglyceridemia and reduced HDL-cholesterol are common in HD patients.
  • Lipoprotein(a) [Lp(a)] and apo(a) isoforms are gaining attention for their role in cardiovascular disease.

Purpose:

  • To compare Lp(a) levels and apo(a) isoform frequencies in patients on maintenance hemodialysis versus normal subjects.
  • To investigate potential associations between Lp(a), apo(a) isoforms, and cardiovascular risk in the HD population.

Summary:

  • Hemodialysis patients exhibited significantly elevated Lp(a) levels compared to controls.
  • HD patients showed a higher prevalence of the S2 apo(a) isoform and a lower prevalence of the S4 isoform.
  • A high frequency of the S2/S3 double band apo(a) isoform was observed in HD patients, particularly those on long-term dialysis.

Impact:

  • This study identifies elevated Lp(a) and specific apo(a) isoform distributions as potential biomarkers for cardiovascular risk in maintenance hemodialysis patients.
  • Findings contribute to understanding the dyslipidemia associated with end-stage renal disease and its cardiovascular complications.
  • Further research may explore therapeutic strategies targeting Lp(a) in this vulnerable patient group.

Related Concept Videos